The Study On Synergy Effect Of Double-crane Merging Beijing Second Pharmaceutical Co.,Ltd.

In recent years,the number of mergers and acquisitions event in China’s pharmaceutical industry continues to rise and the amount involved in those events has been increasing year by year.The pharmaceutical industry has been experiencing an M&A climax.Enterprises in this industry attempt to continuously expand their business scope,enhance the management and accelerate their own external growth through M&A.However,M&A is risky,failures are not rare in M&A events in recent years and synergy effect is the key to the success of mergers and acquisitions.Thus,to objectively evaluate the synergy effect of M&As not only has theoretical significance,but also has more important practical significance.Via analyzing the characteristics of the M&A of China’s pharmaceutical industry,this paper selected the CR Double-Crane M&A events as a case.Evaluate enterprise the operation synergy,management synergy and finance synergy in the case.Through the analysis and evaluation of the case’s merger synergies,this paper finds that how does the pharmaceutical industry enterprises can obtain the merger synergies and hopes the result will be helpful to related enterprises in this industry.The paper is divided into five parts.The first part shows the research the aim,the meanings,and the background.It also shows the contents,the methods and the innovation points.Then I introduce the concept of the merger and acquisition and its synergy effect.Then I introduces the background of the 2 companies to,for the support of the later analysis in the cases.What’s more,I specific introduce the procedure of the case.Next,I prepare the analysis of the case.Finally,on the basis of the final analytical result,this paper summarize the successful experience of the case for the enterprises who will be soon faced with a climax in the pharmaceutical industry.